<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Diabetes Investig</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Diabetes Investig</journal-id>
      <journal-id journal-id-type="doi">10.1111/(ISSN)2040-1124</journal-id>
      <journal-id journal-id-type="publisher-id">JDI</journal-id>
      <journal-title-group>
        <journal-title>Journal of Diabetes Investigation</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2040-1116</issn>
      <issn pub-type="epub">2040-1124</issn>
      <publisher>
        <publisher-name>John Wiley and Sons Inc.</publisher-name>
        <publisher-loc>Hoboken</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26816611</article-id>
      <article-id pub-id-type="pmc">4718098</article-id>
      <article-id pub-id-type="doi">10.1111/jdi.12377</article-id>
      <article-id pub-id-type="publisher-id">JDI12377</article-id>
      <article-categories>
        <subj-group subj-group-type="overline">
          <subject>Letter to the Editor</subject>
        </subj-group>
        <subj-group subj-group-type="heading">
          <subject>Letter to the Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Osmotic demyelination syndrome complicating diabetes with anti&#x2010;glutamic acid decarboxylase antibodies and Graves&#x2019; disease: A case report</article-title>
        <alt-title alt-title-type="left-running-head">Tajitsu <italic>et&#xA0;al</italic>.</alt-title>
      </title-group>
      <contrib-group>
        <contrib id="jdi12377-cr-0001" contrib-type="author">
          <name>
            <surname>Tajitsu</surname>
            <given-names>Machiko</given-names>
          </name>
          <xref ref-type="aff" rid="jdi12377-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="jdi12377-cr-0002" contrib-type="author" corresp="yes">
          <name>
            <surname>Yamada</surname>
            <given-names>Tsutomu</given-names>
          </name>
          <xref ref-type="aff" rid="jdi12377-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="jdi12377-cr-0003" contrib-type="author">
          <name>
            <surname>Cao</surname>
            <given-names>Xia</given-names>
          </name>
          <xref ref-type="aff" rid="jdi12377-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="jdi12377-cr-0004" contrib-type="author">
          <name>
            <surname>Fukui</surname>
            <given-names>Ayako</given-names>
          </name>
          <xref ref-type="aff" rid="jdi12377-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="jdi12377-cr-0005" contrib-type="author">
          <name>
            <surname>Nagai</surname>
            <given-names>Junko</given-names>
          </name>
          <xref ref-type="aff" rid="jdi12377-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="jdi12377-cr-0006" contrib-type="author">
          <name>
            <surname>Yambe</surname>
            <given-names>Yuko</given-names>
          </name>
          <xref ref-type="aff" rid="jdi12377-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="jdi12377-cr-0007" contrib-type="author">
          <name>
            <surname>Murase</surname>
            <given-names>Takashi</given-names>
          </name>
          <xref ref-type="aff" rid="jdi12377-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="jdi12377-cr-0008" contrib-type="author">
          <name>
            <surname>Okada</surname>
            <given-names>Hisashi</given-names>
          </name>
          <xref ref-type="aff" rid="jdi12377-aff-0002">
<sup>2</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="jdi12377-aff-0001">
        <label>
          <sup>1</sup>
        </label>
        <named-content content-type="organisation-division">Department of Endocrinology and Diabetes</named-content>
        <institution>National Hospital Organization</institution>
        <institution>Nagoya Medical Center</institution>
        <named-content content-type="city">Nagoya</named-content>
        <country country="JP">Japan</country>
      </aff>
      <aff id="jdi12377-aff-0002">
        <label>
          <sup>2</sup>
        </label>
        <named-content content-type="organisation-division">Department of Neurology</named-content>
        <institution>National Hospital Organization</institution>
        <institution>Nagoya Medical Center</institution>
        <named-content content-type="city">Nagoya</named-content>
        <country country="JP">Japan</country>
      </aff>
      <author-notes>
        <corresp id="correspondenceTo"><label>*</label>
Corresponding author. Tsutomu Yamada<break/>
Tel.: +81&#x2010;52&#x2010;951&#x2010;1111<break/>
Fax: +81&#x2010;52&#x2010;951&#x2010;0664<break/>
E&#x2010;mail address: <email>yamadat@nnh.hosp.go.jp</email><break/></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>04</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <volume>7</volume>
      <issue>1</issue>
      <issue-id pub-id-type="doi">10.1111/jdi.2016.7.issue-1</issue-id>
      <fpage>130</fpage>
      <lpage>131</lpage>
      <history>
        <date date-type="received">
          <day>19</day>
          <month>2</month>
          <year>2015</year>
        </date>
        <date date-type="rev-recd">
          <day>11</day>
          <month>5</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>12</day>
          <month>5</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2016 Asian Association for the Study of Diabetes and Wiley Publishing Asia Pty Ltd <copyright-statement>-->
        <copyright-statement content-type="article-copyright">&#xA9; 2016 The Authors. Journal of Diabetes Investigation published by Asian Association of the Study of Diabetes (AASD) and Wiley Publishing Asia Pty Ltd</copyright-statement>
        <license license-type="creativeCommonsBy-nc">
          <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">Creative Commons Attribution&#x2010;NonCommercial</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</license-p>
        </license>
      </permissions>
      <self-uri content-type="pdf" xlink:type="simple" xlink:href="file:JDI-7-130.pdf"/>
      <abstract abstract-type="toc" id="jdi12377-abs-0002">
        <p>ODS associated with hyperglycemia is rare, with few reports.Immune responses have been recently reported as a mechanism of ODS onset. In the present case, an autoimmune predisposition may have contributed to ODS pathogenesis.
<boxed-text position="anchor" content-type="graphic" id="jdi12377-blkfxd-0001" orientation="portrait"><graphic xlink:href="JDI-7-130-g002.jpg" position="anchor" id="nlm-graphic-1" orientation="portrait"/></boxed-text>
</p>
      </abstract>
      <counts>
        <page-count count="2"/>
      </counts>
      <custom-meta-group>
        <custom-meta>
          <meta-name>source-schema-version-number</meta-name>
          <meta-value>2.0</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>component-id</meta-name>
          <meta-value>jdi12377</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>cover-date</meta-name>
          <meta-value>January 2016</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>details-of-publishers-convertor</meta-name>
          <meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:4.7.5 mode:remove_FC converted:19.01.2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <p>Osmotic demyelination syndrome (ODS) is a demyelinating brain disease, resulting from a rapid increase in plasma osmolality. However, ODS associated with hyperglycemia is rare, with few reports.</p>
    <p>A 60&#x2010;year&#x2010;old man was presented to Nagoya Medical Center, Nagoya, Japan, after experiencing malaise, lightheadedness, impaired consciousness and disorientation during an outing in extreme heat. He had a propensity to imbalance and falling before hospitalization. On presentation, the patient had impaired consciousness, hypertension, tachycardia, fever and emaciation, with a consciousness level of 13 (E4V3M6) on the Glasgow Coma Scale, blood pressure of 181/94&#xA0;mmHg, pulse rate of 155&#xA0;b.p.m., body temperature of 38.0&#xB0;C and a body mass index of 16.2. Blood sampling showed hyperglycemia, dehydration and ketosis with the following laboratory values: casual blood glucose 667&#xA0;mg/dL; glycated hemoglobin 16.6%; blood urea nitrogen 20&#xA0;mg/dL; serum creatinine 0.69&#xA0;mg/dL; serum Na 132&#xA0;mEq/L; serum K 5.1&#xA0;mEq/L; serum Cl 97&#xA0;mEq/L; serum total ketone bodies 399&#xA0;&#x3BC;mol/L; and plasma osmolality 318&#xA0;mOsm/kg. Blood gas analysis showed no acidosis, and he had no drinking history. The patient was&#xA0;subsequently admitted for treatment.&#xA0;Six hours after treatment with continuous insulin infusion and fluid replacement, the patient's blood glucose level was 317&#xA0;mg/dL, plasma osmolality was 314&#xA0;mOsm/kg and serum Na level was 142&#xA0;mEq/L. Furthermore, concomitant Graves&#x2019; disease became apparent from a thyroid&#x2010;stimulating hormone level of 0.001&#xA0;&#x3BC;IU/mL, free thyroxine level of 2.12&#xA0;ng/dL, thyrotrophin receptor antibody level of 11.1&#xA0;IU/L and increased thyroid blood flow by echogram, for which oral thiamazole was initiated. Type&#xA0;1 diabetes was also suspected from an anti&#x2010;glutamic acid decarboxylase antibody level of 2,723.3&#xA0;U/mL and serum C&#x2010;peptide level of 1.20&#xA0;ng/mL, which was treated with intensive insulin therapy. The patient's disorientation, which included passing vague comments and abnormal behavior, increased after admission; cranial magnetic resonance imaging carried out on hospital day&#xA0;7 showed a high signal intensity area on T2&#x2010;weighted imaging of the central pontine region (Figure&#xA0;<xref rid="jdi12377-fig-0001" ref-type="fig">1</xref>a). He was subsequently diagnosed with ODS&#x2010;induced central pontine myelinolysis. Thereafter, he developed aspiration pneumonitis caused by dysphagia as a bulbar symptom on hospital day&#xA0;12. His disorientation approached the peak on day&#xA0;6, and almost disappeared on day&#xA0;21. The patient's dysphagia disappeared approximately 2&#xA0;months after onset. Cranial magnetic resonance imaging carried out 5&#xA0;months after hospitalization showed an improved high signal intensity area (Figure&#xA0;<xref rid="jdi12377-fig-0001" ref-type="fig">1</xref>b), and his neurological symptoms had almost completely disappeared. He has continued insulin therapy; his glycated hemoglobin increased to 7.4% and serum C&#x2010;peptide level was maintained within 3.40&#xA0;ng/mL 8&#xA0;months after admission.</p>
    <fig fig-type="Figure" xml:lang="en" id="jdi12377-fig-0001" orientation="portrait" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Cranial magnetic resonance imaging (a) on hospital day&#xA0;7, (b) 5&#xA0;months after hospitalization (both T2&#x2010;weighted images; upper image: transaxial view, lower image: coronal view) and (c) cranial computed tomography on admission.</p>
      </caption>
      <graphic id="nlm-graphic-3" xlink:href="JDI-7-130-g001"/>
    </fig>
    <p>ODS often occurs because of a rapid increase in plasma osmolality, and is primarily accompanied by a rapid correction of hyponatremia. In contrast, it has been reported that the onset of ODS mainly results from an increase in plasma osmolality, not an increase in sodium itself<xref rid="jdi12377-bib-0001" ref-type="ref">1</xref>. In previous reports of ODS caused by hyperglycemia<xref rid="jdi12377-bib-0002" ref-type="ref">2</xref>, <xref rid="jdi12377-bib-0003" ref-type="ref">3</xref>, ODS is diagnosed after acute treatment. Therefore, it is not clear whether ODS has already developed before admission, or if it is caused by treatment. In the present case, the serum Na level increased after a decrease in the blood glucose level after admission. However, the drop in plasma osmolality and observation of a pre&#x2010;existing low&#x2010;density area in the central pontine region on computed tomography (Figure&#xA0;<xref rid="jdi12377-fig-0001" ref-type="fig">1</xref>c) on admission suggested that ODS had already occurred by the time of admission.</p>
    <p>Immune responses, such as microglial activation, have recently been reported as a mechanism of ODS onset<xref rid="jdi12377-bib-0004" ref-type="ref">4</xref>, and some&#xA0;previous reports of ODS were concomitant with type&#xA0;1 diabetes<xref rid="jdi12377-bib-0002" ref-type="ref">2</xref>, <xref rid="jdi12377-bib-0003" ref-type="ref">3</xref>. However, it remains unclear if an autoimmune predisposition could have contributed to ODS pathogenesis.</p>
    <sec id="jdi12377-sec-6003">
      <title>Disclosure</title>
      <p>The authors declare no conflict of interest.</p>
    </sec>
  </body>
  <back>
    <ack id="jdi12377-sec-0002">
      <title>Acknowledgment</title>
      <p>This study did not receive any sources of funding.</p>
    </ack>
    <ref-list content-type="cited-references" id="jdi12377-bibl-0001">
      <title>References</title>
      <ref id="jdi12377-bib-0001">
        <label>1</label>
        <mixed-citation publication-type="journal">
<string-name>
<surname>McKee</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Winkelman</surname>
<given-names>MD</given-names>
</string-name>, <string-name>
<surname>Banker</surname>
<given-names>BQ</given-names>
</string-name>. <article-title>Central pontine myelinolysis in severely burned patients: relationship to serum hyperosmolality</article-title>. <source>Neurology</source>
<year>1988</year>; <volume>38</volume>: <fpage>1211</fpage>&#x2013;<lpage>1217</lpage>.<pub-id pub-id-type="pmid">3399069</pub-id></mixed-citation>
      </ref>
      <ref id="jdi12377-bib-0002">
        <label>2</label>
        <mixed-citation publication-type="journal">
<string-name>
<surname>Petzold</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kapellen</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Siekmeyer</surname>
<given-names>M</given-names>
</string-name>, <italic>et&#xA0;al</italic>
<article-title>Acute cerebral infarction and extra pontine myelinolysis in children with new onset type 1 diabetes mellitus</article-title>. <source>Pediatr Diabetes</source>
<year>2011</year>; <volume>12</volume>: <fpage>513</fpage>&#x2013;<lpage>517</lpage>.<pub-id pub-id-type="pmid">21466645</pub-id></mixed-citation>
      </ref>
      <ref id="jdi12377-bib-0003">
        <label>3</label>
        <mixed-citation publication-type="journal">
<string-name>
<surname>Guerrero</surname>
<given-names>WR</given-names>
</string-name>, <string-name>
<surname>Dababneh</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Nadeau</surname>
<given-names>SE</given-names>
</string-name>. <article-title>Hemiparesis, encephalopathy, and extrapontine osmotic myelinolysis in the setting of hyperosmolar hyperglycemia</article-title>. <source>J Clin Neurosci</source>
<year>2013</year>; <volume>20</volume>: <fpage>894</fpage>&#x2013;<lpage>896</lpage>.<pub-id pub-id-type="pmid">23477877</pub-id></mixed-citation>
      </ref>
      <ref id="jdi12377-bib-0004">
        <label>4</label>
        <mixed-citation publication-type="journal">
<string-name>
<surname>Iwama</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sugimura</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Suzuki</surname>
<given-names>H</given-names>
</string-name>, <italic>et&#xA0;al</italic>
<article-title>Time&#x2010;dependent changes in proinflammatory and neurotrophic responses of microglia and astrocytes in a rat model of osmotic demyelination syndrome</article-title>. <source>Glia</source>
<year>2011</year>; <volume>59</volume>: <fpage>452</fpage>&#x2013;<lpage>462</lpage>.<pub-id pub-id-type="pmid">21264951</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
